Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

High-Intensity Interval Training × Endocrine × 1 year × Clear all

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 CNS 1 Breast 1

Interventions

lutetium Lu 177 dotatate 25 Magnetic Resonance Spectroscopy 21 pembrolizumab 17 Specimen Handling 16 Nivolumab 14 Everolimus 14 gallium Ga 68 dotatate 9 cabozantinib 9 Ipilimumab 9 trametinib 8 dabrafenib 8 Cisplatin 8 Carboplatin 8 lenvatinib 7 atezolizumab 6 Temozolomide 6 Capecitabine 6 X-Rays 5 Vemurafenib 5 Injections 5 Fluorodeoxyglucose F18 5 Etoposide 5 Disulfides 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 surufatinib 4 selpercatinib 4 amino-acid, glucose, and electrolyte solution 4 Surveys and Questionnaires 4 Paclitaxel 4 Octreotide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡